Natrixam (Indapamide, Amlodipine Besilate)

Indapamide inhibits sodium reabsorption in the distal renal tubules, increasing urinary water excretion and reducing plasma volume. Amlodipine besilate blocks L‑type calcium channels in vascular smooth muscle, causing arterial relaxation. Together they decrease cardiac preload and systemic vascular resistance, producing a net reduction in blood pressure.

The specific dose of Natrixam is determined by the prescribing healthcare professional based on the patient’s blood pressure, renal function, and concomitant therapies. The prescriber selects the appropriate strength and dosing schedule, which is then reflected on the prescription label. Patients should follow the exact instructions provided by their clinician.

The safety of Natrixam in pregnancy or while breastfeeding has not been definitively established. Because indapamide and amlodipine may cross the placenta or be excreted in breast milk, the medication should only be used if the potential benefit justifies the potential risk to the fetus or infant. Consultation with an obstetrician is essential.

To request Natrixam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with single‑agent therapies, Natrixam offers the convenience of two complementary mechanisms in one tablet, potentially improving adherence. Unlike pure diuretics, the amlodipine component mitigates reflex tachycardia and peripheral edema, while the indapamide component adds diuretic potency. Clinicians may prefer it over separate prescriptions when a combined effect is desired.

Natrixam should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or near heat sources. Do not freeze the tablets.

Natrixam is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water. Patients should not split, crush, or chew the tablet unless specifically instructed, to ensure consistent absorption of both active ingredients.

Serious adverse reactions, although uncommon, may include severe hypotension, electrolyte disturbances such as hyponatremia or hypokalemia, angioedema, hepatic dysfunction, and rare skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience swelling of the face or throat, persistent dizziness, or signs of liver injury.

Natrixam is contraindicated in patients with known hypersensitivity to indapamide, amlodipine, or any excipients in the formulation. It should also be avoided in individuals with severe renal or hepatic impairment, uncontrolled heart failure, or those taking certain interacting medications that could cause dangerous drops in blood pressure. A healthcare professional must evaluate suitability before prescribing.